However, targeting TGFβ has been associated with cardiovascular toxicity and the development of benign tumors, possibly because TGFβ is a pleiotropic cytokine expressed by multiple stromal cell types, some of which are required for normal tissue homeostasis9. The gene discussed is TGFB1; the disease is benign neoplasm.